A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review

Journal of Multidisciplinary Healthcare, Journal Year: 2022, Volume and Issue: Volume 15, P. 21 - 45

Published: Jan. 1, 2022

Abstract: The delay or refusal of vaccination, which defines vaccine hesitancy, is a major challenge to successful control COVID-19 epidemic. huge number publications addressing hesitancy necessitates periodic review provide concise summary acceptance rates worldwide. In the current narrative review, data on were retrieved from surveys in 114 countries/territories. East and Southern Africa (n = 9), highest rate was reported Ethiopia (92%), while lowest Zimbabwe (50%). West/Central 13), Niger (93%), Cameroon (15%). Asia Pacific 16), Nepal Vietnam (97%), Hong Kong (42%). Eastern Europe/Central 7), Montenegro (69%) Kazakhstan (64%), Russia (30%). Latin America Caribbean 20), Mexico (88%), Haiti (43%). Middle East/North (MENA, n 22), Tunisia Iraq (13%). Western/Central Europe North 27), Canada (91%) Norway (89%), Cyprus Portugal (35%). ≥ 60% seen 72/114 countries/territories, compared 42 countries/territories with between 13% 59%. phenomenon appeared more pronounced MENA, Central Asia, Africa. More studies are recommended Africa, address intentions general public get vaccination. Keywords: SARS-CoV-2, hesitance, resistance, rejection, willingness vaccinate, intention vaccinate

Language: Английский

---

Using Social and Behavioral Science to Support COVID-19 Pandemic Response

Springer eBooks, Journal Year: 2023, Volume and Issue: unknown, P. 1 - 41

Published: Jan. 1, 2023

Language: Английский

---

Impact of low vaccine coverage on the resurgence of COVID-19 in Central and Eastern Europe

One Health, Journal Year: 2022, Volume and Issue: 14, P. 100402 - 100402

Published: May 19, 2022

The coronavirus disease 2019 (COVID-19) pandemic has caused a tremendous global impact both socially and economically. mechanisms behind the disparity in severity, vaccine coverage, variant replacement patterns across European countries are unclear. In this work, we aim to reveal possible reasons via data visualization model fitting. We developed with vaccination component simulate mortality waves these countries. Deaths averted by campaign were estimated. Finally, discuss potential differences coverage Contemporary transportation trade bring significant convenience our daily life but also facilitate spread of novel virus COVID-19 anywhere globally within short time. observations results work highlight importance mitigate future pandemics under One Health approach.

Language: Английский

---

Understanding hesitancy with revealed preferences across COVID-19 vaccine types

Scientific Reports, Journal Year: 2022, Volume and Issue: 12(1)

Published: Aug. 2, 2022

Many countries have secured larger quantities of COVID-19 vaccines than their population is willing to take. The abundance and the large variety created not only an unprecedented intensity vaccine related public discourse, but also a historical moment understand hesitancy better. Yet, heterogeneity by types has been neglected in existing literature so far. We address this problem analysing acceptance assessment five types. use information collected with nationally representative survey at end third wave pandemic Hungary. During vaccination campaign, individuals could reject assigned wait for more preferred alternative that enables us quantify revealed preferences across find heterogenous driven individuals' trusted source information. Believers conspiracy theories are likely evaluate mRNA (Pfizer Moderna) unacceptable. Those who follow advice politicians vector-based (AstraZeneca Sputnik) or whole-virus (Sinopharm) acceptable. argue greater selection available free choice individual desirable conditions increase rate societies.

Language: Английский

---

Divergent COVID-19 vaccine policies: Policy mapping of ten European countries

Vaccine, Journal Year: 2023, Volume and Issue: 41(17), P. 2804 - 2810

Published: March 22, 2023

The COVID-19 pandemic highlighted the fragmented nature of governmental policy decisions in Europe. However, extent to which vaccination policies differed between European countries remains unclear. Here, we mapped that were effect January 2022 as well booster regulations April Austria, Denmark, England, France, Germany, Ireland, Italy, Netherlands, Poland, and Spain.National public health experts from these ten nations developed completed an electronic questionnaire. questionnaire included a series questions addressed six critical components vaccine implementation, including (1) authorization, (2) prioritization, (3) procurement distribution, (4) data collection, (5) administration, (6) mandate requirements.Our findings revealed significant variations across We observed differences formulations authorized for use, specific groups provided with priority access. also identified discrepancies how vaccination-related recorded each country what requirements implemented.Each surveyed this study reported different policies. These complicated efforts provide coordinated response. might alert policymakers Europe need coordinate their avoid fostering divergent socially disruptive

Language: Английский

---

COVID-19 Vaccine Refusal and Delay among Adults in Italy: Evidence from the OBVIOUS Project, a National Survey in Italy

Vaccines, Journal Year: 2023, Volume and Issue: 11(4), P. 839 - 839

Published: April 13, 2023

Vaccine hesitancy was defined by the World Health Organization (WHO) in 2019 as a major threat to global health. In Italy, reluctance receive vaccines is widespread phenomenon that amplified during COVID-19 pandemic fear and mistrust government. This study aims depict different profiles characteristics of people reluctant vaccinate, focusing on drivers those who are favor opposed receiving vaccine.

Language: Английский

---

Emotional profiling and cognitive networks unravel how mainstream and alternative press framed AstraZeneca, Pfizer and COVID-19 vaccination campaigns

Scientific Reports, Journal Year: 2022, Volume and Issue: 12(1)

Published: Aug. 24, 2022

Abstract COVID-19 vaccines have been largely debated by the press. To understand how mainstream and alternative media vaccines, we introduce a paradigm reconstructing time-evolving narrative frames via cognitive networks natural language processing. We study Italian news articles massively re-shared on Facebook/Twitter (up to 5 million times), covering 5745 vaccine-related from 17 outlets over 8 months. find consistently high trust/anticipation low disgust in way sources framed “vaccine/vaccino”. These emotions were crucially missing outlets. News titles “AstraZeneca” with sadness, absent titles. Initially, linked mostly “Pfizer” side effects (e.g. “allergy”, “reaction”, “fever”). With temporary suspension of “AstraZeneca”, negative associations shifted: Mainstream prominently effects, while underwent positive valence shift, its higher efficacy. Simultaneously, thrombosis fearful conceptual entered frame death changed context, i.e. rather than hopefully preventing deaths, could be reported as potential causes death, increasing fear. Our findings expose crucial aspects emotional narratives around adopted press, highlighting need report vaccination news.

Language: Английский

---

Application of Traditional Vaccine Development Strategies to SARS-CoV-2

mSystems, Journal Year: 2023, Volume and Issue: 8(2)

Published: March 2, 2023

Over the past 150 years, vaccines have revolutionized relationship between people and disease. During COVID-19 pandemic, technologies such as mRNA received attention due to their novelty successes. However, more traditional vaccine development platforms also yielded important tools in worldwide fight against SARS-CoV-2 virus. A variety of approaches been used develop that are now authorized for use countries around world. In this review, we highlight strategies focus on viral capsid outwards, rather than nucleic acids inside. These fall into two broad categories: whole-virus subunit vaccines. Whole-virus virus itself, either an inactivated or attenuated state. Subunit contain instead isolated, immunogenic component Here, candidates apply these different ways. a companion manuscript, review recent novel nucleic-acid based technologies. We further consider role programs played prophylaxis at global scale. Well-established proved especially making accessible low- middle-income countries. Vaccine established undertaken much wider range those using nucleic-acid-based technologies, which led by wealthy Western Therefore, platforms, though less from biotechnological standpoint, proven be extremely management SARS-CoV-2.

Language: Английский

---

Uptake of COVID-19 and influenza vaccines in relation to preexisting chronic conditions in the European countries

BMC Geriatrics, Journal Year: 2024, Volume and Issue: 24(1)

Published: Jan. 12, 2024

Abstract Background The suboptimal uptake of COVID-19 and influenza vaccines among those with non-communicable chronic diseases is a public health concern, because it poses higher risk severe illness for individuals underlying conditions, emphasizing the need to address barriers vaccination ensure adequate protection this vulnerable population. In present study, we aimed identify whether people illnesses are more likely get vaccinated against in European Union. Methods Cross-sectional data on 49,253 men (n = 20,569) women 28,684) were obtained from ninth round Survey Health, Ageing Retirement Europe (June – August, 2021). outcome variables self-reported vaccine status. association between six preexisting conditions including high blood pressure, cholesterol, lung disease, diabetes, bronchitis, asthma was estimated using binary logistic regression methods. Results coverage ranged close 100% Denmark (98.2%) Malta less than 50% Bulgaria (19.1%) Romania (32.7%). countries highest percentage participants included (66.7%), Spain (63.7%) Netherlands (62.5%), lowest (3.7%), Slovakia (5.8%) Poland (9.2%). Participants pressure 3% [Risk difference (RD) -0.03, 95% CI -0.04, -0.03] report taking [RD CI= -0.01] vaccine. Those disease 4% -0.06, 2% [RD= -0.02, Men have reported both vaccines. Conclusions Current findings indicate adult EU countries. take

Language: Английский

---

Factors associated with vaccine hesitancy against COVID-19 among adults in Europe: a descriptive study analysis applying socio-ecological framework

BMC Research Notes, Journal Year: 2024, Volume and Issue: 17(1)

Published: March 19, 2024

Abstract Objective This study aimed to explore the factors associated with COVID-19 vaccine hesitancy in Europe among adults by using Socio-Ecological Model. Results cross-sectional used secondary data collected from respondents residing 27 EU countries at time of May 2021. The outcome was against COVID-19, and total sample size 23,606 analysed binary logistic regression, as well McKelvey Zavonoia’s R 2 . After adding each level variables, model found significant increased association younger age groups (21–39 years 40–60 vs. 65 years+), who left full-time education a young (16–19 years), those manual jobs, children home, individuals small towns, beliefs related vaccine. Together, levels explained 49.5% variance hesitancy, addition variable layer variance. highlights need consider broad multiple enhance acceptance uptake.

Language: Английский

---